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ABSTRACT
Background Community-acquired pneumonia (CAP) is
a major cause of mortality and morbidity in many
countries but few recent large-scale studies have
examined trends in its incidence.
Methods Incidence of CAP leading to hospitalisation
in one UK region (Oxfordshire) was calculated over
calendar time using routinely collected diagnostic codes,
and modelled using piecewise-linear Poisson regression.
Further models considered other related diagnoses,
typical administrative outcomes, and blood and
microbiology test results at admission to determine
whether CAP trends could be explained by changes in
case-mix, coding practices or admission procedures.
Results CAP increased by 4.2%/year (95% CI 3.6 to
4.8) from 1998 to 2008, and subsequently much faster
at 8.8%/year (95% CI 7.8 to 9.7) from 2009 to 2014.
Pneumonia-related conditions also increased signiﬁcantly
over this period. Length of stay and 30-day mortality
decreased slightly in later years, but the proportions with
abnormal neutrophils, urea and C reactive protein (CRP)
did not change (p>0.2). The proportion with severely
abnormal CRP (>100 mg/L) decreased slightly in later
years. Trends were similar in all age groups.
Streptococcus pneumoniae was the most common
causative organism found; however other organisms,
particularly Enterobacteriaceae, increased in incidence
over the study period (p<0.001).
Conclusions Hospitalisations for CAP have been
increasing rapidly in Oxfordshire, particularly since 2008.
There is little evidence that this is due only to changes
in pneumonia coding, an ageing population or patients
with substantially less severe disease being admitted
more frequently. Healthcare planning to address
potential further increases in admissions and consequent
antibiotic prescribing should be a priority.
Community-acquired pneumonia (CAP) is a
major cause of mortality and morbidity worldwide,
particularly among people over 65 years of age,1 2
and is a key driver for antibiotic prescribing. Given
the ageing population in high-income countries and
concerns over antibiotic resistance, it is surprising
how little research has investigated the burden CAP
places on our hospitals. For example, the two
large-scale studies investigating pneumonia inci-
dence in English hospitals3 4 showed a marked
increase in admissions from 1997 to 2005 and
2002 to 2009 respectively, but no studies have
reported more recent trends.
Beyond an actual increase in disease, the
increases reported have many potential explana-
tions, including changes in case-mix, improvements
in diagnostic coding, changes in preferred codes
(eg, ‘sepsis’ rather than ‘pneumonia’5) or changing
admission practices, for example, admitting lower-
severity cases. However, most research to date has
used only administrative coding data sets, such as
the UK Hospital Episode Statistics or the US
National (Nationwide) Inpatient Sample, which
alone are unable to assess disease severity at presen-
tation to hospital, and hence whether or not this
affects admission practices.
We therefore used the Infections in Oxfordshire
Research Database (IORD)6 to investigate the
hypothesis that changes in incidence of hospitalisa-
tions for CAP in Oxfordshire adults over the past
16 years could be explained by changes in
case-mix, coding practices, disease severity at
admission or bacterial aetiology.
METHODS
IORD contains all admissions to the Oxford
University Hospitals NHS Foundation Trust from
Key messages
What is the key question?
▸ UK hospitalisations for pneumonia were found
to be increasing more than expected between
1997 and 2009, but what is happening now,
and is there anything we should be worrying
about?
What is the bottom line?
▸ There is an alarming ongoing increase in
pneumonia hospitalisations (at least in
Oxfordshire), as well as changes in bacterial
aetiology which have implications for antibiotic
prescribing.
Why read on?
▸ We show that the increase is not just due to
changes in population, documentation or
admission practices by triangulating frequently
used but arguably subjective data such as
diagnostic codes against more reliably objective
data such as laboratory tests.
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April 1997 to date, linked with microbiology and biochemistry/
haematology laboratory results. The four Trust hospitals provide
all acute care and all microbiology and pathology services in the
region (∼600 000 individuals). Out-of-hospital mortality is
determined from a national information system into which
UK-wide deaths are recorded.
This analysis considered UK ﬁnancial years (April–March)
ending 1998–2014 inclusive (avoiding splitting the winter peak
across 2 years) and included only patients ≥18 years at admission.
To restrict to community-acquired cases, we only included patients
with a primary diagnostic code of pneumonia admitted to special-
ties where CAP would normally present, that is, acute general medi-
cine (300), infectious diseases (350), emergency department (180),
respiratory medicine (340) and geriatric medicine (430). If an
admission contained multiple consultant episodes, only the ﬁrst epi-
sode’s codes were used. Over the study period, these specialties
accounted for 17 489/18 785 (93%) adult pneumonia admissions.
All primary diagnostic codes in these specialties were grouped into
diagnostically distinct categories by an acute medicine physician
(referring to the Clinical Classiﬁcations software7), and reviewed by
an infectious diseases specialist (see online supplementary material).
We also excluded all day cases (where a patient temporarily
requires a bed but is not expected to stay overnight (173/17 489
(1%) adult pneumonia admissions)) as day cases had been
recorded in different ways in different years. Trends in annual
incidence were modelled using Poisson regression, with ﬁnancial
year as the only explanatory variable, and allowing a change in
trend where this signiﬁcantly improved model ﬁt (see online
supplementary methods; in brief, the deviance goodness-of-ﬁt
statistic from models allowing a change in trend at each calendar
year between 2000 and 2012 inclusive were compared,8 and the
lowest deviance two-trend model compared with the model
with a single trend using a χ2 test). To assess whether any
changes in pneumonia incidence merely reﬂected changes in
admissions in general, we separately modelled adult admissions
(to the same specialties) for other common infections, all non-
pneumonic infections and all non-infectious causes, comparing
rates across different diagnosis groups using stacked regression.
In sensitivity analyses, we modelled only the ﬁrst pneumonia
episode per person per year, as well as only the ﬁrst pneumonia
episode per person recorded since April 1997 (to determine if
changes were driven by increases/decreases in readmissions
rather than actual disease). We also separately considered cases
of pneumonia where the patient had not been in hospital in the
preceding 14 days, to exclude the possibility of them having
acquired their pneumonia during a previous hospital admission.
Case-mix and population growth
Pneumonia disproportionately affects older people so to control
for this we standardised admissions for age (and sex) for each
year against the 1998 Oxfordshire population, and also adjusted
for overall population size. Population estimates were obtained
from the UKOfﬁce for National Statistics.9
Comorbidities also increase with age, and are often controlled
for by calculating the Charlson comorbidity score10 for each
episode. However, the completeness of secondary diagnostic
codes has substantially improved over time11 (see online supple-
mentary figure S1), and so the Charlson comorbidity score
cannot be relied upon to measure comorbidities consistently
over long time periods (see online supplementary figure S2).
Diagnostic coding
Under clinical uncertainty or multiple diagnoses, the choice of
primary diagnostic code depends on many factors, including
documentation quality, the clinical coder’s experience,12 the
higher monetary tariff paid for certain codes, and quality
improvement projects that may encourage the use of certain
codes. Therefore, pneumonia cases may potentially be mis-
labelled as another lower respiratory disorder or vice versa, so
we also modelled the incidence over time of likely alternative
diagnoses, namely COPD, other lower respiratory tract infec-
tions, sepsis and non-speciﬁc viral infection (see online
supplementary material). ‘Diagnostic-code- switching’ would be
suggested if these incidence trends were opposite to that of
pneumonia.
Disease severity and aetiology
To assess whether changes in disease severity of those being
admitted to hospital could be contributing to changes in pneu-
monia incidence, we ﬁrst considered those measures available in
other administrative data sets, namely the outcomes length of
stay, 30-day all-cause mortality and 30-day readmission. The
major limitation of using such outcomes to assess CAP severity
at presentation is that they are inﬂuenced by numerous factors
during admission, for example, delayed discharge for social
reasons or administrative changes in bed policy. As more robust
measures of severity we therefore also modelled the median C
reactive protein (CRP), urea and absolute neutrophil count
(closest value within ±2 days of admission), as well as the pro-
portion of these test results falling outside prescribed thresholds
(CRP: >20 and >100 mg/L,13 urea: >7 mmol/L,14 neutrophils:
<2 or >7 ×109/L (hospital laboratory reference range)). Results
from the Horton laboratory (which closed in October 2003
when all testing was transferred to a single site) were not avail-
able, and so only test results available for complete ﬁnancial
years were included, and a step-change added to the models at
this time point to allow for case-mix differences between the
hospitals. Test results were therefore available in 67–70% CAP
admissions annually before 2004 and 90–97% thereafter.
Finally, we modelled the incidence and proportion of CAP
admissions where microbiology cultures of blood or high-quality
respiratory samples (ie, pleural ﬂuid or bronchoalveolar lavage)
were taken (within ±2 days of admission), and any likely causa-
tive agents found (see online supplementary material). Where
there were multiple microbiological tests within the window, the
earliest positive pleural ﬂuid sample was taken where available,
otherwise the earliest positive blood sample, otherwise the earli-
est positive bronchoalveolar lavage sample. CAP sputum
samples are not routinely analysed at the hospital laboratory
owing to poor reliability and so were not considered. Similarly
to the haematology/biochemistry tests, microbiology results
from the Horton laboratory were not available so only results
available for complete ﬁnancial years were included.
Trends in length of stay and median biomarkers were mod-
elled using median (quantile) regression, and in other outcomes
using Poisson regression. All analyses were conducted using
Stata V.13.1.
RESULTS
Between April 1997 and March 2014 there were 407 774 adult
admissions into the relevant specialties, comprising 195 489
individuals. Of these admissions, 17 316 were for CAP. Just over
half of CAP admissions (52%) were men and this proportion
did not change signiﬁcantly over time (p=0.53). Median age
increased over time (p<0.001) from 74 years in 1997/1998 to
80 years in 2013/2014.
Raw CAP admissions rose from 598 in 1997/1998 to 1677 in
2013/2014, an overall rise of 180% (ﬁgure 1A). However, there
2 Quan TP, et al. Thorax 2016;0:1–8. doi:10.1136/thoraxjnl-2015-207688
Respiratory infection
group.bmj.com on March 14, 2016 - Published by http://thorax.bmj.com/Downloaded from 
was strong evidence (p<0.001) this had not occurred uniformly,
with admissions increasing by 4.2%/year (95% CI 3.6 to 4.8)
through 2007/2008, but by 8.8%/year (95% CI 7.8 to 9.7)
afterwards (table 1). Faster annual incidence increases post 2008
persisted after controlling for population changes (p<0.001 vs
model with no trend-change), although the absolute increases
were smaller. Annual incidence increases were also signiﬁcantly
faster post 2008 when including only the ﬁrst pneumonia
episode per person per year (p<0.001), and faster post 2007
when including only the ﬁrst pneumonia episode per person
ever recorded (p<0.001), eliminating the possibility that read-
missions were driving overall increases. Patterns remained
similar when excluding patients who had been in hospital in the
preceding 14 days. Very few admissions (<30/year) were
recorded as coming from nursing homes.
Admissions for other conditions which might be alternatively
diagnosed as pneumonia also increased signiﬁcantly during this
time (ﬁgure 1A and table 1). However, in contrast to pneumo-
nia, increases in COPD and in other lower respiratory infections
were faster before 2005 and 2007, respectively, than subse-
quently, suggesting some diagnosis-code switching could be
occurring. Comparing current incidence rates, CAP incidence
rose signiﬁcantly faster than COPD and other lower respiratory
infections (p<0.001 and p=0.001, respectively), but there was
no evidence of difference in trends compared with sepsis and
non-speciﬁc viral infections (p=0.34 and p=0.98, respectively).
CAP incidence also rose signiﬁcantly faster compared with all
the above conditions grouped together (p<0.001).
Admissions for other common infections also increased during
the period (ﬁgure 1B), with lower urinary tract infections, skin
and soft tissue infections, and upper respiratory infections all cur-
rently rising at signiﬁcantly lower rates (p<0.001) than pneumo-
nia, while gastroenteritis is currently rising signiﬁcantly faster
(p<0.001). However, lower urinary tract infections and gastro-
enteritis had very late trend-change points (2012 and 2011,
respectively), and prior to this there was no evidence that either
diagnosis was rising at a different rate to post-2008 pneumonia
(p=0.45 and p=0.40, respectively).
Overall admissions (into the relevant specialties) increased,
though with a current trend signiﬁcantly slower than CAP
(p<0.001). Similarly, admissions for all non-pneumonic infec-
tions and for all non-infections also increased over the study
period (ﬁgure 1C), but with current trends signiﬁcantly slower
than CAP (p=0.02 and p<0.001, respectively).
Considering administrative outcomes of adult CAP admis-
sions, 30-day all-cause mortality ranged from 22% to 29% over
the study, increasing by 1.8%/year from 1998 to 2007 then
decreasing by 3.1%/year (table 2). Median length of stay stayed
constant at ∼6 days from 1998 to 2005, then decreased by
0.25 days/year. Trends were similar in all age groups (ﬁgure 2).
This suggests the threshold for admitting patients with CAP
could have lowered in recent years, and/or care had improved.
However, while 2–5% of patients were readmitted with pneu-
monia (as primary diagnosis) within 30 days of discharge, this
signiﬁcantly increased over the study, and similarly, all-cause
readmissions increased from 2002 onwards. Competing-risks
regression15 also conﬁrmed that readmissions were increasing
signiﬁcantly faster than deaths post discharge (sub-HR=1.07/
year (1.05 to 1.09)).
Considering biomarkers that should reﬂect disease severity at
presentation more accurately than postadmission outcomes,
median CRP increased slightly up to 2009 then decreased
slightly thereafter (table 3); however, levels remained signiﬁ-
cantly elevated (median 94 mg/L in 2014). The proportion of
results over 100 mg/L was stable up to 2009 at ∼52% then
decreased by 2.3%/year. Other biomarkers were mostly stable,
with median urea increasing slightly up to 2004 then remaining
at ∼7.8 mmol/L, and median neutrophil counts stable up to
2011 then decreasing slightly thereafter (median 9.7×109/L in
2014). The proportion of these tests which were outside rele-
vant thresholds did not change substantially over time (p=0.21,
p=0.73, respectively). Again, trends were similar in all age
groups (ﬁgure 2).
Between 53% and 69% of CAP admissions annually had
blood or high-quality respiratory cultures performed, with this
proportion decreasing over time (table 4), as did the proportion
Figure 1 Annual admissions for speciﬁc diagnostic groups. (A)
Pneumonia versus similar diagnostic conditions (B) Pneumonia versus
other common infections (C) Pneumonia versus all other codes.
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with a positive culture result. However, because of the overall
increase in CAP, the absolute numbers of CAP admissions with
these cultures taken, and with positive culture results, increased
over time. The most common organism overall was
Streptococcus pneumoniae (48% of cases where a causative
organism was found), followed by Escherichia coli (11%) and
Staphylococcus aureus (7%). Incidence of CAP primarily asso-
ciated with Enterobacteriaceae increased signiﬁcantly over the
study period (E. coli: 9.8%/year, p<0.001; Klebsiella spp:
12.3%/year, p=0.001; other Enterobacteriaceae: 10.6%/year,
p=0.001) (ﬁgure 3), as did cases associated with anaerobes/
Streptococcus ‘milleri’ group bacteria (13.6%/year, p=0.01).
Incidence of other traditional CAP-related organisms did not
change signiﬁcantly (S. pneumoniae: p=0.63; S. aureus:
p=0.84; Haemophilus inﬂuenzae: p=0.50; Pseudomonas aeru-
ginosa: p=0.25; other Gram-positives: p=0.25; other
Gram-negatives: p=0.22). The increasing incidence of
Enterobacteriaceae-associated CAP persisted even when exclud-
ing individuals who had been in hospital in the previous 14 days
(see online supplementary figure S3); and the median (IQR)
time from admission to specimen collection was −0.7 (−4.1 to
4.0) hours, suggesting this is highly unlikely to be driven by mis-
classiﬁed hospital-acquired pneumonia.
DISCUSSION
Hospital admissions for CAP are currently increasing by ∼9%
per year among Oxfordshire adults and cannot be attributed
simply to a growing, ageing population. This is not an artefact
Table 1 Annual trends in incidence of admissions for pneumonia and other related diagnoses (to Acute General Medicine and related
specialties)
Initial % change
per year (95% CI)
Year of
rate-change*
Subsequent % change
per year (95% CI)
Direction of
change†
Estimate in
2014‡
Pneumonia admissions
Unadjusted 4.2 (3.6 to 4.8) 2008 8.8 (7.8 to 9.7) ↑ ↑ 1668
Standardised for age, sex and population size 2.0 (1.4 to 2.6) 2008 5.1 (4.2 to 6.1) ↑ ↑ n/a
Excluding readmissions in same (financial) year 4.1 (3.5 to 4.7) 2008 8.2 (7.2 to 9.1) ↑ ↑ 1528
Excluding readmissions at any later date 3.0 (2.3 to 3.7) 2007 6.9 (6.1 to 7.8) ↑ ↑ 1318
Excluding those discharged from our hospitals in the previous
14 days
3.6 (3.0 to 4.3) 2008 8.4 (7.5 to 9.4) ↑ ↑ 1425
Possible alternative diagnoses
COPD 5.5 (4.6 to 6.5) 2005 1.9 (1.3 to 2.5) ↑ ↑ 1076
Other lower respiratory tract infections 9.1 (8.2 to 10.0) 2007 2.9 (2.0 to 3.9) ↑ ↑ 885
Sepsis 4.4 (3.1 to 5.6) 2011 13.5 (8.0 to 19.3) ↑ ↑ 217
Non-specific viral infection 2.8 (1.3 to 4.2) 2010 8.7 (4.2 to 13.3) ↑ ↑ 156
All pneumonia-like diagnoses 5.7 (5.1 to 6.2) 2005 4.6 (4.3 to 5.0) ↑ ↑ 3926
Other common infections
Lower urinary tract infections 9.5 (9.0 to 10.0) 2012 −0.6 (−3.9 to 2.7) ↑ ↔ 1067
Skin and soft tissue infections 6.5 (5.1 to 7.9) 2005 0.7 (−0.2 to 1.6) ↑ ↔ 502
Upper respiratory tract infections 3.9 (2.8 to 5.0) – ↑ 115
Gastroenteritis 10.1 (8.7 to 11.4) 2011 45.4 (40.0 to 51.0) ↑ ↑ 564
Overall admissions
All admissions 6.2 (6.0 to 6.4) 2006 1.6 (1.5 to 1.8) ↑ ↑ 29 438
All infections (excluding pneumonia) 7.1 (6.6 to 7.6) 2006 5.7 (5.3 to 6.1) ↑ ↑ 4601
All non-infections 6.2 (6.1 to 6.4) 2006 0.7 (0.5 to 0.8) ↑ ↑ 23 274
All trends modelled using piecewise linear Poisson regression. See Methods for included specialties.
*Allowing change in trend over time if significant improvement over linear trend alone (p<0.05), with year of the change point chosen by profile likelihood8 (see Methods).
†Single arrows represent direction of change over the whole time period; paired arrows represent direction and relative size of change in the periods before and after the year when
data suggested trend in rates changed (as in *).
‡Number of admissions, as estimated by the best-fitting model as presented in the table.
Table 2 Annual trends in administrative data outcomes (in those admitted for pneumonia)
Initial change* per year (95%
CI)
Year of
rate-change†
Subsequent change* per year (95%
CI)
Direction of
change‡
Estimate in
2014§
30-day mortality 1.8 (0.4 to 3.1) 2007 −3.1 (−4.5 to −1.7) ↑ ↓ 0.22
30-day readmission
All-cause 10.0 (4.2 to 16.1) 2002 1.5 (0.4 to 2.6) ↑ ↑ 0.16
Pneumonia 3.4 (1.7 to 5.2) − ↑ 0.04
Median length of stay
(days)
0.00 (−0.06 to 0.06) 2006 −0.25 (−0.30 to −0.20) ↔ ↓ 4
Length of stay modelled using piecewise median regression, all other trends using piecewise linear Poisson regression.
*Percentage change in rate trend for mortality, readmission; absolute change in median length of stay.
†Allowing change in trend over time if significant improvement over linear trend alone (p<0.05), with year of the change point chosen by profile likelihood8 (see Methods).
‡Single arrows represent direction of change over the whole time period; paired arrows represent direction and relative size of change in the periods before and after the year when
data suggested trend in rates changed (as in †).
§Proportion of admissions/median value, as estimated by the best-fitting model as presented in the table.
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of repeat admissions for the same illness episode nor an increase
in hospital-acquired pneumonia as trends persisted when exclud-
ing all readmissions and when excluding those with any previ-
ous recent hospitalisations, respectively. Additionally, trends in
admissions for reasons other than pneumonia differ signiﬁcantly
to CAP (table 1 and ﬁgure 1C), suggesting that the increases are
not merely a reﬂection of overall changes in admission numbers.
The rise is also not explainable by ‘diagnosis-code-switching’
since hospitalisations for other, similar, diagnoses also increased
during the same time period. However, the fact that pneumonia
diagnoses increased at a faster rate after 2008 while COPD and
other lower respiratory infections started to increase more
slowly at around the same time suggests some limited
diagnosis-switching could still be occurring.
An alternative explanation for the CAP increase is that more
low-severity cases are presenting to hospital (where previously
they were managed in primary care), and the decrease in length
of stay and 30-day all-cause mortality over the latter part of the
study period supports this hypothesis. However, the fact that
readmissions for pneumonia increased over this time supports
another plausible explanation for the shortening length of stay,
namely an increased pressure for early discharge. The propor-
tion of CAP admissions where blood or high-quality respiratory
cultures were requested (a potential indicator of moderate-high
severity), as well as CRP, also decreased in the latter part of the
study; however urea and neutrophils stayed fairly stable, and the
actual magnitude of the CRP change was very small, with most
individuals still having clearly abnormal values. Therefore there
Figure 2 Administrative outcomes and admission biomarkers for all community-acquired pneumonia admissions. (A) 30-day all-cause mortality
rate (B) median length of stay (C) 30-day readmission rate (with pneumonia) post discharge (D) median C reactive protein (CRP) at admission (E)
median urea at admission (F) median neutrophil count at admission. Vertical line represents step-change in availability of laboratory test results (see
Methods).
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does not seem to have been a clear shift towards admitting
more low-severity cases, and despite the proportion of pneumo-
nia cases warranting blood/respiratory cultures decreasing, the
actual numbers of these cases (and therefore burden of CAP
judged sufﬁciently severe to warrant requesting them) has con-
tinued to increase.
The main study strength lies in the use of linked electronic
health records, which allow for triangulation of frequently used
but arguably subjective data such as diagnostic codes, against
more reliably objective data such as laboratory tests. Accuracy
and completeness of diagnostic coding has changed over time11
as hospitals have adjusted to Payment by Results16 and to the
publication of standardised mortality ratios, so relying on
coding alone carries inherent risks. Although we have not
attempted to measure the accuracy of the primary coding used
in our hospitals, previous studies suggest it is sufﬁcient for epi-
demiological analysis.11 17 18 We have, however, considered
‘diagnostic-code-switching’ in detail, as well as used only
primary codes, which are subject to regular national audit.19
Furthermore, linkage to national mortality data provides a more
accurate outcome measure than the inhospital mortality used in
most studies based on administrative data.20
However, this strength is also the main limitation, since we
are unable to investigate underlying mechanisms or speciﬁc
Table 3 Annual trends in admission biomarkers (in those admitted for pneumonia)
Initial change* per year
(95% CI)
Year of
rate-change†
Subsequent change* per year
(95% CI)
Direction of
change‡
Estimate in
2014§
Median CRP (mg/L) 2.68 (0.18 to 5.17) 2009 −4.60 (−6.48 to −2.72) ↑ ↓ 94
Median urea (mmol/L) 0.12 (0.02 to 0.21) 2004 −0.01 (−0.05 to 0.03) ↑ ↔ 7.8
Median neutrophils (×109/L) 0.04 (−0.02 to 0.10) 2011 −0.16 (−0.28 to −0.04) ↔ ↓ 9.7
Proportion CRP >20 mg/L −0.1 (−0.8 to 0.6) – ↔ 0.84
Proportion CRP >100 mg/L 1.0 (−1.1 to 3.1) 2009 −2.3 (−3.8 to −0.7) ↔ ↓ 0.48
Proportion urea >7 mmol/L 0.5 (−0.3 to 1.3) – ↔ 0.58
Proportion neutrophils <2 or
>7×109/L
−0.1 (−0.8 to 0.6) – ↔ 0.75
Median values modelled using piecewise median regression, all other trends using piecewise linear Poisson regression.
*Absolute change in median values, percentage change in rate trend for proportions outside thresholds (out of those which had a test).
†Allowing change in trend over time if significant improvement over linear trend alone (p<0.05), with year of the change point chosen by profile likelihood8 (see Methods).
‡Single arrows represent direction of change over the whole time period; paired arrows represent direction and relative size of change in the periods before and after the year when
data suggested trend in rates changed (as in †).
§Proportion of admissions/median value, as estimated by the best-fitting model as presented in the table.
CRP, C reactive protein.
Table 4 Annual trends in microbiology results (in those admitted for pneumonia)
Initial % change per year
(95% CI)
Year of
rate-change*
Subsequent % change per year
(95% CI)
Direction of
change†
Estimate in
2014‡
Proportion of pneumonias with
Blood or high-quality respiratory
culture taken
−3.9 (−5.5 to −2.2) 2004 −1.1 (−1.9 to −0.3) ↓ ↓ 0.62
Any potentially causative bacterial
organism found
−3.4 (−5.6 to −1.1) – ↓ 0.05
Incidence of pneumonia with
Blood or high-quality respiratory
culture taken
2.1 (0.5 to 3.8) 2007 7.2 (6.3 to 8.2) ↑ ↑ 1024
Any potentially causative bacterial
organism found
3.8 (1.3 to 6.3) – ↑ 78
S. pneumoniae −1.0 (−4.4 to 2.5) – ↔ 29
S. aureus 0.2 (−8.4 to 9.6) – ↔ 5
E. coli 9.8 (5.4 to 14.5) – ↑ 12
Klebsiella spp 12.3 (4.8 to 20.2) – ↑ 5
P. aeruginosa 8.6 (−5.6 to 25.0) – ↔ 3
H. influenzae 4.5 (−7.7 to 18.3) – ↔ 3
Other Enterobacteriaceae 10.6 (4.4 to 17.3) – ↑ 6
Anaerobes/S. Milleri 13.6 (2.8 to 25.6) – ↑ 3
Other Gram-positives 2.3 (−1.5 to 6.3) – ↔ 8
Other Gram-negatives 35.0 (−16.6 to 118.6) – ↔ 1
Mixed organisms 7.8 (0.8 to 15.4) − ↑ 4
All trends modelled using piecewise linear Poisson regression.
*Allowing change in trend over time if significant improvement over linear trend alone (p<0.05), with year of the change point chosen by profile likelihood8 (see Methods).
†Single arrows represent direction of change over the whole time period; paired arrows represent direction and relative size of change in the periods before and after the year when
data suggested trend in rates changed (as in *).
‡Proportion/number of admissions, as estimated by the best-fitting model as presented in the table.
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factors, for example, specimen quality, in more detail. The ethic-
ally approved database does not contain general practice data,
so we cannot assess pneumonia incidence in general practice,
although other studies have done this.21 We also cannot identify
whether gradual changes were made in referral practice during
the study period, although there was no evidence of a major
impact of the reorganisation of out-of-hours service in 2004.
Even within our hospital data, two key tests routinely used to
diagnose and assess pneumonia were not available, namely chest
X-rays and blood gases, neither were other clinical data such as
blood pressure and respiratory rate. While these would have
given additional information, the lack of clinically relevant
changes in other important severity biomarkers suggests they
would be unlikely to produce substantially different results.
Other potentially confounding factors that cannot be accounted
for in any study using secondary data include those caused by
changes in organisational culture or not recorded in the hospital
systems; however, we could not identify any major changes in
healthcare provision that co-occurred with the increase in pneu-
monia trend from 2008. Our study is in a single hospital group,
and a recent study investigating CAP in people over 65 years of
age in the UK community21 found an unexpectedly high overall
rate in the South Central region (which our hospitals serve), for
reasons which are unclear, so further studies are needed to
explore the generalisability of these ﬁndings. However, this may
be challenging with the routinely collected data available, as to
our knowledge there is only one other UK hospital group with a
comparable database linking admissions to laboratory tests.
In the USA, sepsis has been shown to be a likely candidate for
diagnosis-switching, leading to the appearance of falling pneumo-
nia rates between 2003 and 2009,5 which may not be genuine.
However it is not the cause of the pneumonia increases we report
here, since it is still relatively uncommon in our hospitals (<200
primary diagnoses in relevant specialties in 2014), and also dis-
plays an increasing trend. A more recent US study22 which
counted sepsis diagnoses together with pneumonia found an
overall increase between 1993 and 2011, while in Denmark, there
was a large national increase in the pneumonia hospitalisation rate
between 1997 and 2011.23 However, unlike our analysis, all these
studies used diagnosis codes in isolation. We were not able to iden-
tify other large population-based studies, somewhat surprisingly
given the importance of pneumonia as a cause of admission.
Our ﬁndings raise two major questions—ﬁrst what is the
cause for the observed increases in CAP, and second, regardless
of cause, what should we do about it? We have investigated
several potential causes, but further possibilities include changes
in levels of deprivation, an increase in comorbidities not cap-
tured within our data (given the confounding of the Charlson
comorbidity score by coding depth (see online supplementary
ﬁgures S1 and S2)) and reduced access to out-of-hours primary
care leading people to come directly to hospital. Nevertheless, it
is likely that multiple factors are contributing to the increase,
rather than there being a single cause. Historically, pneumonia
has been considered predominantly bacterial in aetiology, with
S. pneumoniae the leading organism.24 25 However, we found a
causative organism relatively rarely, in only 5% of cases in 2014
(8% where a culture was performed), potentially because of
emphasis on early antibiotic initiation in emergency admis-
sions,26 though also likely due to inherent difﬁculties in isolating
organisms using culture-based methods. Vaccination pro-
grammes27 have signiﬁcantly reduced the incidence of invasive
pneumococcal disease in southern England28 29 (although not
everywhere4), but S. pneumoniae was still the most common
causative organism found. However, its dominance is decreas-
ing, and other organisms, particularly Enterobacteriaceae such
as E. coli and Klebsiella spp are becoming more prevalent. This
is particularly concerning given their high rates of resistance to
empirical antibiotics commonly recommended for CAP.30 31
Although these pathogens have traditionally been viewed as
associated with hospital-acquired pneumonia, we found similar
CAP trends in patients without any recent previous hospital
exposure, and specimens were taken very close to admission,
suggesting this is highly unlikely to be driven by misclassiﬁed
hospital-acquired pneumonia. There were no changes in hospital
procedures regarding specimen collection processing that could
have caused this: in any case such changes would be associated
with an immediate incidence change rather than the gradual
year-on-year increase we observed.
Respiratory tract infections are the most common indication
for hospital antibiotic prescribing in the UK, accounting for over
30% of prescriptions.32 Thus CAP increases will drive increases
in antibiotic prescribing and, unaddressed, hinder our best
attempts to reduce antibiotic use, a key priority given increasing
antimicrobial resistance. Animal studies suggest that antibiotic-
driven microbiota depletion can impair subsequent responses to
inﬂuenza33 and bacterial challenges,34 raising the intriguing possi-
bility that increasing use of antibiotics to treat presumed bacterial
infections could actually be having the unintended consequence
of increasing their incidence. Further respiratory microbiome
studies could investigate this hypothesis in humans. We are
unable to assess whether non-microbiologically conﬁrmed CAP
was actually viral with the data available, and while H1N1 pan-
demic inﬂuenza may have been partially responsible for increases
in 2009/2010, this would not explain the ever-increasing trend.
Developing rapid point-of-care diagnostics to identify viral versus
bacterial aetiology will be crucial to support the clinician in bal-
ancing the timely administration of antibiotics (emphasised by
national26 and international35 guidelines), against reducing
unnecessary antibiotic prescriptions. A better understanding of
short-course or tailored antibiotic durations may also assist in
reducing antibiotic exposure.
In summary, this study suggests that rather than discounting
increases in pneumonia admissions as simply indicative of a
growing, ageing population, or an artefact of documentation or
healthcare-seeking behaviour, we should be actively searching
for the reasons behind the increase, as well as planning our
healthcare systems appropriately—for the increase in admissions
—and to mitigate the potential ‘collateral damage’ of
Figure 3 Microbiologically conﬁrmed community-acquired pneumonia
spells by causative organism (taken within 2 days of admission).
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antimicrobial resistance that may otherwise be seen as more and
more patients are treated for pneumonia.
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